Amicus Therapeutics saw the highest growth of 2.49% in patent filings in June and 2.99% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 2.24% and grants by 0.05%. GlobalData’s DataBook provides a comprehensive analysis of Amicus Therapeutics‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Amicus Therapeutics has been focused on protecting inventions in European Patent Office(EPO) with 13 publications in Q2 2024
The European Patent Office(EPO) Patent Office dominates the patent filings with nearly 30% of filings. The European Patent Office(EPO), United States(US), Hungary(HU), and World Intellectual Property Organization(WIPO) patent Office are among the top ten patent offices where Amicus Therapeutics is filings its patents. Among the top granted patent authorities, Amicus Therapeutics has 100% of its grants in Spain(ES).
Amgen could be the strongest competitor for Amicus Therapeutics
Patents related to rare diseases and healthtech lead Amicus Therapeutics's portfolio
Amicus Therapeutics has the highest number of patents in rare diseases followed by, healthtech and genomics. For rare diseases, nearly 90% of patents were filed and 100% of patents were granted in Q2 2024.
Fabry disease related patents lead Amicus Therapeutics portfolio followed by pompe disease, and proteinuria
Amicus Therapeutics has highest number of patents in fabry disease followed by pompe disease, proteinuria, mobiles, hand-helds, pdas, smartphones, and healthcare it. For fabry disease, nearly 38% of patents were filed and 40% of patents were granted in Q2 2024.
For comprehensive analysis of Amicus Therapeutics's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
